Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
boceprevir (victrelis) (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
ribavirin (virazole) (1 trial)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis C (Phase 4)
Hepatitis C, Chronic (Phase 4)
Hepatitis, Chronic (Phase 4)
Kidney Diseases (Phase 4)
Kidney Failure, Chronic (Phase 4)
Trials (1 total)
Trial APIs (3 total)